Press Release Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics Jul 6
Press Release Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712 Jul 2